Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stem-Like Signature Predicting Disease Progression in Early Stage Bladder Cancer. The Role of E2F3 and SOX4

2 Aug 2018

Abstract excerpt

The rapid development of the cancer stem cells (CSC) field, together with powerful genome-wide screening techniques, have provided the basis for the development of future alternative and reliable therapies aimed at targeting tumor-initiating cell populations. Urothelial bladder cancer stem cells (BCSCs) that were identified for the first time in 2009 are heterogenous and originate from multiple cell types;...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30072631
DOI: 10.3390/biomedicines6030085

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stem-Like Signature Predicting Disease Progression in Early Stage Bladder Cancer. The Role of E2F3 and SOX4PMID 30072631Read ↗

Sox4 Expression Confers Bladder Cancer Stem Cell Properties and Predicts for Poor Patient OutcomeSemantic proximity Read ↗

Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder CancerSemantic proximity Read ↗

Bladder cancer stem cells: clonal origin and therapeutic perspectivesSemantic proximity Read ↗

A stemness-related seven-gene signature for predicting prognosis and treatment response in muscle invasive bladder cancerSemantic proximity Read ↗

SOX2 Is a Marker for Stem-like Tumor Cells in Bladder CancerSemantic proximity Read ↗

scRNA-seq reveals epithelial heterogeneity in bladder cancer and establishes a cancer stem cell prognostic modelSemantic proximity Read ↗

The expression of cancer stem cells and its effects on the propensity for recurrence and metastasis in bladder cancer: a systematic reviewSemantic proximity Read ↗

A Cell of Origin Gene Signature Indicates Human Bladder Cancer Has Distinct Cellular ProgenitorsSemantic proximity Read ↗

Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2Semantic proximity Read ↗

Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder CancerSemantic proximity Read ↗

Bladder Cancer Initiating Cells (BCICs) Are Among EMA<sup>−</sup>CD44v6<sup>+</sup>Subset: Novel Methods for Isolating Undetermined Cancer Stem (Initiating) CellsSemantic proximity Read ↗

Single-cell Sequencing Reveals Variants in ARID1A, GPRC5A and MLL2 Driving Self-renewal of Human Bladder Cancer Stem Cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.